Physician profile
Naveen D Bhandarkar
NPI 1205010360
$638,961.08
in general payments reported to CMS, 2019-2025
16 companies · $95K in 2025
The $95K reported for 2025 was more than what 98% of Otolaryngic Allergy providers received nationally (typical 2025 total: $449).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $107K · 2020: $77K · 2021: $56K · 2022: $114K · 2023: $88K · 2024: $103K · 2025: $95K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $220K · Travel and Lodging: $44K · Food and Beverage: $12K · Consulting Fee: $10K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $219,528.60 |
| Travel and Lodging | $44,118.05 |
| Food and Beverage | $11,576.04 |
| Consulting Fee | $10,285.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $455,383.51 | 2019-2025 | |
| Stryker Corporation | $88,554.12 | 2019-2025 | Scopis Ent, Xpress Ent Dilation System, Tgs Guidewire |
| Glaxosmithkline, LLC. | $67,873.13 | 2023-2025 | Nucala |
| Regeneron Healthcare Solutions, INC. | $6,478.36 | 2023-2025 | Dupixent |
| Acclarent, INC | $5,575.82 | 2019-2023 | Trudi Nav Cable |
| Intersect Ent, INC. | $4,884.62 | 2019-2022 | |
| Medtronic USA, INC. | $4,379.34 | 2019-2020 | |
| Medtronic, INC. | $3,150.63 | 2021-2024 | Fusion, Propel, Nuvent |
| Genzyme Corporation | $832.00 | 2025 | |
| Aerin Medical INC. | $657.35 | 2019-2025 | |
| Astrazeneca Pharmaceuticals Lp | $520.23 | 2025 | Tezspire |
| Integra Lifesciences Corporation | $428.63 | 2024-2025 | Inspira Air, Acclarent Aera, Trudi Probe |
| Inspire Medical Systems, INC. | $126.02 | 2024 | Inspire |
| Novartis Pharmaceuticals Corporation | $64.88 | 2019 | |
| 3-D Matrix, INC. | $52.44 | 2024 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Naveen Bhandarkar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.